Section 330A(e) of the Public Health Service Act, as Amended (42 U.S.C. 254c(e)) and Section 317(k)(2) of the Public Health Service Act, as Amended (42 U.S.C. 247b(k)(2)), 34767-34768 [E9-16959]
Download as PDF
mstockstill on DSKH9S0YB1PROD with NOTICES
Federal Register / Vol. 74, No. 136 / Friday, July 17, 2009 / Notices
with an affinity for CD47 for the
preservation or resuscitation of organs
and tissues for transplantation’’; (2) ‘‘the
use of antibodies including humanized
antibodies reacting with CD47 or related
antigens, precursors, or molecules, and
isolated and/or recombinant fragments,
and conjugates with an affinity for CD47
for treating or preventing vascular
diseases, including but not limited to,
pulmonary hypertension, sickle cell
disease, myocardial infarction, stroke,
and tissue ischemia resulting from
trauma and surgical procedures’’; (3)
‘‘the use of antisense oligonucleotides or
RNA formulations of stabilized
composition to reduce expression of
CD47 for treating wounds and/or burns
and for use in reconstructive surgery’’;
and (4) ‘‘use of small molecules
antagonists of CD47 for treating or
preventing vascular diseases including,
but not limited to, thrombosis,
hypertension, peripheral artery disease,
renal artery disease, and ischemia
resulting from atherosclerosis’’ to
Vasculox, Inc., having an office in at
least St. Louis, Missouri, U.S.A. The
patent rights in these inventions have
been assigned to the United States of
America.
DATES: Only written comments and/or
applications for a license which are
received by the NIH Office of
Technology Transfer on or before
September 15, 2009 will be considered.
ADDRESSES: Requests for copies of the
patent application, inquiries, comments,
and other materials relating to the
contemplated exclusive license should
be directed to: Charlene A. Sydnor,
Ph.D., Licensing and Patenting Manager,
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville, MD
20852–3804; Telephone: (301) 435–
4689; Facsimile: (301) 402–0220; E-mail:
sydnorc@mail.nih.gov.
SUPPLEMENTARY INFORMATION: Nitric
Oxide (NO) plays an important role as
a major intrinsic vasodilator, and
increases blood flow to tissues and
organs. Disruption of this process leads
to peripheral vascular disease, ischemic
heart disease, stroke, diabetes and many
more significant diseases. The inventors
have discovered that the matrix protein
thrombospondin1 (TSP1) blocks the
beneficial effects of NO, and prevents it
from dilating blood vessels and
increasing blood flow to organs and
tissues. Additionally, they discovered
that this regulation requires TSP1
interaction with its cell receptor, CD47.
Relief of this inhibition in genetically
altered mice lacking either TSP1 or
CD47 results in dramatically improved
blood flow and increased tissue
VerDate Nov<24>2008
19:20 Jul 16, 2009
Jkt 217001
oxygenation. Further, by using reagents
such as monoclonal antibodies and
peptides that block TSP1–CD47
interaction, or agents such as antisense
oligonucleotides or morpholinos that
reduce the level of CD47 or TSP1, blood
flow can dramatically increase to
ischemic tissues in vivo. Inhibition of
TSP1 signaling at the level of CD47
expression and/or activation
significantly improves the survival of
tissue in an ischemic environment.
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR part 404.7. The
prospective exclusive license may be
granted unless within sixty (60) days
from the date of this published notice,
the NIH receives written evidence and
argument that establishes that the grant
of the license would not be consistent
with the requirements of 35 U.S.C. 209
and 37 CFR part 404.7.
Applications for a license in the field
of use filed in response to this notice
will be treated as objections to the grant
of the contemplated exclusive license.
Comments and objections submitted to
this notice will not be made available
for public inspection and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: July 10, 2009.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E9–17038 Filed 7–16–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Section 330A(e) of the Public Health
Service Act, as Amended (42 U.S.C.
254c(e)) and Section 317(k)(2) of the
Public Health Service Act, as Amended
(42 U.S.C. 247b(k)(2))
AGENCY: Health Resources and Services
Administration, HHS.
ACTION: Notice of Single Source Grant
Award to Lincoln County Health
Department in Libby, MT.
SUMMARY: The Health Resources and
Services Administration (HRSA) is
issuing a new single source award
through the Rural Health Care Services
Outreach Grant Program and the Centers
for Disease Control and Prevention’s
(CDC) screening grant program authority
to Lincoln County Health Department
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
34767
(LCHD) in Libby, Montana. A serious
public health problem has been
identified in Lincoln County, Montana,
as residents in this rural community
have been adversely affected by the
asbestos released from a vermiculite
mine. The asbestos-related diseases in
which Lincoln County residents have
been diagnosed include asbestosis, lung
cancer, mesothelioma, and others. The
purpose of this demonstration grant
would be to provide care management
for Lincoln County residents with
asbestos-related diseases. The grant will
provide funds to support the
coordination and payment of care for
asbestos-related diseases among such
entities as hospitals, clinics, specialty
care providers, and others involved in
the care and treatment of this service
population.
SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award:
Lincoln County Health Department in
Libby, Montana.
Amount of the Award FY 2009: It is
anticipated that up to $6,000,000 will be
available from all sources for a 2-year
project period from August 1, 2009—
July 31, 2011. Of the $6,000,000,
$2,000,000 will be available from CDC
to support this effort. The remaining
$4,000,000 will be awarded by HRSA’s
Office of Rural Health Policy’s Rural
Health Care Services Outreach Program,
of which $2,000,000 will be provided
the first year and an additional
$2,000,000 will be provided the second
year. Funding beyond the first year,
however, is dependent on the
availability of appropriated funds,
grantee satisfactory performance, and a
decision that continued funding is in
the best interest of the Federal
Government.
Project Period: The project period for
this grant is August 1, 2009, through
July 31, 2011.
Authority: This activity is funded
under the authority of HRSA’s Rural
Health Care Services Outreach Program,
statutory authority Section 330A(e) of
the Public Health Service Act, as
amended (42 U.S.C. 254c(e)); and the
CDC’s statutory authority Section
317(k)(2) of the Public Health Service
Act, as amended (42 U.S.C. 247b(k)(2)).
The authority for the single source
award is HHS Grants Policy Directive
2.04, Awarding Grants.
Catalogue of Federal Domestic
Assistance Number: HRSA’s Rural
Health Care Services Outreach Grant:
93.912. CDC Screening Program: 93.161.
Justification for Single Source
Awards: Because of the serious public
health problem in Lincoln County,
Montana, and the prevalence of
E:\FR\FM\17JYN1.SGM
17JYN1
34768
Federal Register / Vol. 74, No. 136 / Friday, July 17, 2009 / Notices
asbestos-related diseases among the
residents, their health is at risk of being
severely impaired by lack of essential
screening and related medical
treatment. Due to the urgency of the
situation, HRSA cannot run a full or
limited competition since this process
would take approximately 290 days.
LCHD has been identified as uniquely
qualified for undertaking this activity.
LCHD has the requisite administrative
and medical infrastructure as well as
prior experience with screening and
coordinating treatment with other local
health care providers. In addition,
tracking of disease incidents is a
necessary component of the award
activity and LCHD has previously
worked with the Montana Department
of Public Health and Human Services in
developing and maintaining their
asbestos-related disease registry. LCHD
is in a unique position to immediately
undertake and coordinate the award
activities necessary to address this
urgent public health problem and in a
manner minimizing adverse health
outcomes that might otherwise result
from an extended delay in providing
such services.
FOR FURTHER INFORMATION CONTACT: Tom
Morris, Associate Administrator, Office
of Rural Health Policy, Health Resources
and Services Administration, 5600
Fishers Lane, Rockville, MD 20857;
phone 301–443–0835; tmorris@hrsa.gov.
Dated: July 10, 2009.
Mary K. Wakefield,
Administrator.
[FR Doc. E9–16959 Filed 7–16–09; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2009–0001]
mstockstill on DSKH9S0YB1PROD with NOTICES
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
AGENCY: Federal Emergency
Management Agency, DHS.
ACTION: Notice; 30-day notice and
request for comments; new information
collection; OMB No. 1660–NW35;
FEMA Form 528–1, NEFRLS
Registration; and FEMA Form 528–2,
NEFRLS Search.
SUMMARY: The Federal Emergency
Management Agency (FEMA) has
submitted the information collection
abstracted below to the Office of
Management and Budget for review and
VerDate Nov<24>2008
19:20 Jul 16, 2009
Jkt 217001
clearance in accordance with the
requirements of the Paperwork
Reduction Act of 1995. The submission
describes the nature of the information
collection, the categories of
respondents, the estimated burden (i.e.,
the time, effort and resources used by
respondents to respond) and cost, and
includes the actual data collection
instruments FEMA will use.
Comments must be submitted on
or before August 17, 2009.
DATES:
Submit written comments
on the proposed information collection
to the Office of Information and
Regulatory Affairs, Office of
Management and Budget. Comments
should be addressed to the Desk Officer
for the Department of Homeland
Security, Federal Emergency
Management Agency, and sent via
electronic mail to
oira.submission@omb.eop.gov or faxed
to (202) 395–5806.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the information collection
should be made to Director, Records
Management Division, 1800 South Bell
Street, Arlington, VA 20598–3005,
facsimile number (202) 646–3347, or email address FEMA–InformationCollections@dhs.gov.
SUPPLEMENTARY INFORMATION:
Collection of Information
Title: National Emergency Family
Registry and Locator System (NEFRLS).
Type of information collection: New
information collection.
OMB Number: 1660–NW35.
Form Titles and Numbers: FEMA
Form 528–1, NEFRLS Registration; and
FEMA Form 528–2, NEFRLS Search.
Abstract: NEFRLS is a Web-based
system. The information collected in the
NEFRLS will be used to help facilitate
the reunification of family members that
have been displaced due to a major
disaster or emergency.
Affected Public: Individuals or
households.
Estimated Number of Respondents:
446,648.
Frequency of Response: On Occasion.
Estimated Average Hour Burden per
Respondent: .74 Hours.
Estimated Total Annual Burden
Hours: 328,366.
Estimated Cost: There is no start-up,
operational or other costs associated
with this information collection.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Dated: July 10, 2009.
Larry Gray,
Director, Records Management Division,
Office of Management, Federal Emergency
Management Agency, Department of
Homeland Security.
[FR Doc. E9–17068 Filed 7–16–09; 8:45 am]
BILLING CODE 9111–23–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2009–0001]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
AGENCY: Federal Emergency
Management Agency, DHS.
ACTION: Notice; 60-day notice and
request for comments; revision of a
currently approved information
collection; OMB No. 1660–0085; No
Form.
SUMMARY: The Federal Emergency
Management Agency, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take this opportunity to
comment on a proposed revision of a
currently approved information
collection. In accordance with the
Paperwork Reduction Act of 1995, this
Notice seeks comments concerning the
Crisis Counseling Assistance and
Training Program for Immediate
Services which provides funding in
response to a State’s request for crisis
counseling services for a Presidentiallydeclared disaster.
DATES: Comments must be submitted on
or before September 15, 2009.
ADDRESSES: To avoid duplicate
submissions to the docket, please use
only one of the following means to
submit comments:
(1) Online. Submit comments at
https://www.regulations.gov under
docket ID FEMA–2009–0001. Follow the
instructions for submitting comments.
(2) Mail. Submit written comments to
Office of Chief Counsel, Regulation and
Policy Team, DHS/FEMA, 500 C Street,
SW., Room 835, WASH, DC 20472–
3100.
(3) Facsimile. Submit comments to
(703) 483–2999.
(4) E-mail. Submit comments to
FEMA-POLICY@dhs.gov. Include docket
ID FEMA–2009–0001 in the subject line.
All submissions received must
include the agency name and docket ID.
Regardless of the method used for
E:\FR\FM\17JYN1.SGM
17JYN1
Agencies
[Federal Register Volume 74, Number 136 (Friday, July 17, 2009)]
[Notices]
[Pages 34767-34768]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-16959]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Section 330A(e) of the Public Health Service Act, as Amended (42
U.S.C. 254c(e)) and Section 317(k)(2) of the Public Health Service Act,
as Amended (42 U.S.C. 247b(k)(2))
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice of Single Source Grant Award to Lincoln County Health
Department in Libby, MT.
-----------------------------------------------------------------------
SUMMARY: The Health Resources and Services Administration (HRSA) is
issuing a new single source award through the Rural Health Care
Services Outreach Grant Program and the Centers for Disease Control and
Prevention's (CDC) screening grant program authority to Lincoln County
Health Department (LCHD) in Libby, Montana. A serious public health
problem has been identified in Lincoln County, Montana, as residents in
this rural community have been adversely affected by the asbestos
released from a vermiculite mine. The asbestos-related diseases in
which Lincoln County residents have been diagnosed include asbestosis,
lung cancer, mesothelioma, and others. The purpose of this
demonstration grant would be to provide care management for Lincoln
County residents with asbestos-related diseases. The grant will provide
funds to support the coordination and payment of care for asbestos-
related diseases among such entities as hospitals, clinics, specialty
care providers, and others involved in the care and treatment of this
service population.
SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award: Lincoln County Health Department
in Libby, Montana.
Amount of the Award FY 2009: It is anticipated that up to
$6,000,000 will be available from all sources for a 2-year project
period from August 1, 2009--July 31, 2011. Of the $6,000,000,
$2,000,000 will be available from CDC to support this effort. The
remaining $4,000,000 will be awarded by HRSA's Office of Rural Health
Policy's Rural Health Care Services Outreach Program, of which
$2,000,000 will be provided the first year and an additional $2,000,000
will be provided the second year. Funding beyond the first year,
however, is dependent on the availability of appropriated funds,
grantee satisfactory performance, and a decision that continued funding
is in the best interest of the Federal Government.
Project Period: The project period for this grant is August 1,
2009, through July 31, 2011.
Authority: This activity is funded under the authority of HRSA's
Rural Health Care Services Outreach Program, statutory authority
Section 330A(e) of the Public Health Service Act, as amended (42 U.S.C.
254c(e)); and the CDC's statutory authority Section 317(k)(2) of the
Public Health Service Act, as amended (42 U.S.C. 247b(k)(2)). The
authority for the single source award is HHS Grants Policy Directive
2.04, Awarding Grants.
Catalogue of Federal Domestic Assistance Number: HRSA's Rural
Health Care Services Outreach Grant: 93.912. CDC Screening Program:
93.161.
Justification for Single Source Awards: Because of the serious
public health problem in Lincoln County, Montana, and the prevalence of
[[Page 34768]]
asbestos-related diseases among the residents, their health is at risk
of being severely impaired by lack of essential screening and related
medical treatment. Due to the urgency of the situation, HRSA cannot run
a full or limited competition since this process would take
approximately 290 days.
LCHD has been identified as uniquely qualified for undertaking this
activity. LCHD has the requisite administrative and medical
infrastructure as well as prior experience with screening and
coordinating treatment with other local health care providers. In
addition, tracking of disease incidents is a necessary component of the
award activity and LCHD has previously worked with the Montana
Department of Public Health and Human Services in developing and
maintaining their asbestos-related disease registry. LCHD is in a
unique position to immediately undertake and coordinate the award
activities necessary to address this urgent public health problem and
in a manner minimizing adverse health outcomes that might otherwise
result from an extended delay in providing such services.
FOR FURTHER INFORMATION CONTACT: Tom Morris, Associate Administrator,
Office of Rural Health Policy, Health Resources and Services
Administration, 5600 Fishers Lane, Rockville, MD 20857; phone 301-443-
0835; tmorris@hrsa.gov.
Dated: July 10, 2009.
Mary K. Wakefield,
Administrator.
[FR Doc. E9-16959 Filed 7-16-09; 8:45 am]
BILLING CODE 4165-15-P